A Role in the Pathogenesis of Atherosclerosis,” in
Drugs Affecting Lipid Metabolism (Kluwer Academic
Publishers, 1993), 407–20.
9. J. Uribarri et al., “Circulating Glycotoxins and Dietary
Advanced Glycation Endproducts: Two Links to
Inflammatory Response, Oxidative Stress, and Aging,”
Journals of Gerontology, Series A: Biological Sciences
and Medical Sciences 62, no. 4 (2007): 427–33.
10. P. I. Moreira et al., “Oxidative Stress and
Neurodegeneration,” Annals of the New York Academy
of Sciences 1043 (2005): 545–52.
11. N. Sasaki et al., “Advanced Glycation End Products in
Alzheimer’s Disease and Other Neurodegenerative
Diseases,” American Journal of Pathology 153, no. 4
(1998): 1149–55.
12. M. S. Beeri et al., “Serum Concentration of an
Inflammatory Glycotoxin, Methylglyoxal, Is Associated
with Increased Cognitive Decline in Elderly
Individuals,” Mechanisms of Ageing and Development
132, no. 11–12 (2011): 583–87; K. Yaffe et al.,
“Advanced Glycation End Product Level, Diabetes, and
Accelerated Cognitive Aging,” Neurology 77, no. 14
(2011): 1351–56; Weijing Cai et al., “Oral Glycotoxins
Are a Modifiable Cause of Dementia and the Metabolic
Syndrome in Mice and Humans,” Proceedings of the
National Academy of Sciences 111, no. 13 (2014):
4940–45.
13. American Academy of Neurology, “Lower Blood
Sugars May Be Good for the Brain,” ScienceDaily,
October 23, 2013,
john hannent
(John Hannent)
#1